Literature DB >> 2930456

Purification of a growth factor related to platelet-derived growth factor and a type beta transforming growth factor secreted by mouse neuroblastoma cells. A general strategy for the purification of basic polypeptide growth factors.

A J Van den Eijnden-Van Raaij1, I Koornneef, T M Van Oostwaard, A Feyen, W Kruijer, S W De Laat, E J Van Zoelen.   

Abstract

A general strategy was developed for the purification of basic polypeptide growth factors. This method is a combination of gel filtration, weak-cation-exchange h.p.l.c. and reverse-phase h.p.l.c., separating the proteins according to size, charge and hydrophobicity respectively. All steps are carried out at low pH with exclusively volatile acidic buffer solutions. The sterile conditions and easy removal of salt by freeze-drying facilitate the detection of the growth factors by biological assays. By using this method, homogeneous preparations of two basic growth factors were purified in high yield from mouse-neuroblastoma-Neuro-2A-cell-conditioned medium. It is shown that these purified factors are biochemically and immunologically related to platelet-derived growth factor and type beta transforming growth factor from human platelets.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2930456      PMCID: PMC1135590          DOI: 10.1042/bj2570375

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

1.  The role of polypeptide growth factors in phenotypic transformation of normal rat kidney cells.

Authors:  E J van Zoelen; T M van Oostwaard; S W de Laat
Journal:  J Biol Chem       Date:  1988-01-05       Impact factor: 5.157

2.  Platelet-derived growth factor: purification and partial characterization.

Authors:  C H Heldin; B Westermark; A Wasteson
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

3.  Cation-exchange high-performance liquid chromatography: separation of highly basic proteins using volatile acidic solvents.

Authors:  A J van den Eijnden-van Raaij; I Koornneef; T M van Oostwaard; S W de Laat; E J van Zoelen
Journal:  Anal Biochem       Date:  1987-05-15       Impact factor: 3.365

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  PC13 embryonal carcinoma cells produce a heparin-binding growth factor.

Authors:  J H van Veggel; T M van Oostwaard; S W de Laat; E J van Zoelen
Journal:  Exp Cell Res       Date:  1987-04       Impact factor: 3.905

6.  Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins.

Authors:  C R Merril; D Goldman; S A Sedman; M H Ebert
Journal:  Science       Date:  1981-03-27       Impact factor: 47.728

7.  Chemical and biological properties of a growth factor from human-cultured osteosarcoma cells: resemblance with platelet-derived growth factor.

Authors:  C H Heldin; B Westermark; A Wasteson
Journal:  J Cell Physiol       Date:  1980-11       Impact factor: 6.384

8.  Human melanoma cell lines of primary and metastatic origin express the genes encoding the chains of platelet-derived growth factor (PDGF) and produce a PDGF-like growth factor.

Authors:  B Westermark; A Johnsson; Y Paulsson; C Betsholtz; C H Heldin; M Herlyn; U Rodeck; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

9.  Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors.

Authors:  R Derynck; D V Goeddel; A Ullrich; J U Gutterman; R D Williams; T S Bringman; W H Berger
Journal:  Cancer Res       Date:  1987-02-01       Impact factor: 12.701

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  5 in total

1.  Stimulation of rat endothelial cell transforming growth factor-beta production by bleomycin.

Authors:  S H Phan; M Gharaee-Kermani; F Wolber; U S Ryan
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

2.  Transforming growth factor-beta production in anti-glomerular basement membrane disease in the rabbit.

Authors:  T Coimbra; R Wiggins; J W Noh; S Merritt; S H Phan
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

3.  Fibronectin is the major fibroblast chemoattractant in rabbit anti-glomerular basement membrane disease.

Authors:  M Gharaee-Kermani; R Wiggins; F Wolber; M Goyal; S H Phan
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

4.  Immunomodulatory properties of platelet factor 4: prevention of concanavalin A suppressor-induction in vitro and augmentation of an antigen-specific delayed-type hypersensitivity response in vivo.

Authors:  E O Gregg; L Yarwood; M J Wagstaffe; D S Pepper; M C Macdonald
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

5.  Bradykinin-induced growth inhibition of normal rat kidney (NRK) cells is paralleled by a decrease in epidermal-growth-factor receptor expression.

Authors:  E J Van Zoelen; P H Peters; G B Afink; S Van Genesen; D G De Roos; W Van Rotterdam; A P Theuvenet
Journal:  Biochem J       Date:  1994-03-01       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.